Menu Search
Equities

Mckesson Corp

MCK:NYQ

Mckesson Corp

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (USD)623.19
  • Today's Change-5.08 / -0.81%
  • Shares traded512.78k
  • 1 Year change+36.23%
  • Beta0.4705
Data delayed at least 15 minutes, as of Nov 23 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy6
Outperform10
Hold3
Sell0
Strong Sell0

Share price forecast in USD

The 16 analysts offering 12 month price targets for McKesson Corp have a median target of 667.50, with a high estimate of 715.00 and a low estimate of 534.20. The median estimate represents a 7.11% increase from the last price of 623.19.
High14.7%715.00
Med7.1%667.50
Low-14.3%534.20

Dividends in USD

In 2024, Mckesson Corp reported a dividend of 2.32 USD, which represents a 14.85% increase over last year. The 8 analysts covering the company expect dividends of 2.66 USD for the upcoming fiscal year, an increase of 14.78%.
Div growth (TTM)14.85%
More ▼

Earnings history & estimates in USD

On Nov 06, 2024, McKesson Corp reported 2nd quarter 2025 earnings of 7.07 per share. This result was in line with the consensus of the 15 analysts following the company and exceeded last year's 2nd quarter results by 13.48%.
The next earnings announcement is expected on Feb 05, 2025.
Average growth rate+5.33%
McKesson Corp reported annual 2024 earnings of 27.44 per share on May 07, 2024.
Average growth rate+17.01%
More ▼

Revenue history & estimates in USD

McKesson Corporation had 2nd quarter 2025 revenues of 93.65bn. This bettered the 89.33bn consensus of the 13 analysts covering the company. This was 25.73% above the prior year's 2nd quarter results.
Average growth rate+5.28%
McKesson Corporation had revenues for the full year 2024 of 308.59bn. This was 11.52% above the prior year's results.
Average growth rate+7.56%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.